PROVIDER PROFILE · NPI 1972576304
James Flanagan
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
87
Beneficiaries
—
Total drug cost
$267
Distinct drugs
2
Brand share
16.1%
Top prescribed drugs
Amoxicillin73 claims
Albuterol Sulfate14 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
21.3
Cost
66.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where James Flanagan's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Eve Santiago Physician Assistant · Birmingham, AL | 79 | 304 |
| Richard May Internal Medicine · Birmingham, AL | 45 | 250 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 22 | 65 |
| Mark Maldia Internal Medicine · Birmingham, AL | 18 | 121 |
| Shane Wear Diagnostic Radiology · Hoover, AL | 18 | 73 |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | 17 | 40 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE